join fridays semaglutide Compounded (GLP-1) Switching from Mochi Health to

10mg vial + 2mL BAC water 5mg/mL (5,000mcg/mL)

Key Benefits: Skin Brightening & Lightening: Inhibits tyrosinase, the enzyme responsible for melanin production, leading to a lighter, more even, and radiant complexion

Recently, the GIP/GLP-1R co-agonist tirzepatide has gone through several randomized controlled trials and was approved by the FDA for T2DM and obesity in 2022 and 2023, respectively

for a 300-pound patient up to five times the average weight loss seen with traditional diet and exercise plans

If your provider believes you would benefit from GLP-1 therapy, compounded semaglutide is the accessible option